Inactive Instrument

Analyst Reco. Danaher Corporation Nyse

Equities

DHR PRA

US2358513008

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

Danaher Insider Sold Shares Worth $2,386,325, According to a Recent SEC Filing	05-17	MT
Danaher Insider Sold Shares Worth $4,866,675, According to a Recent SEC Filing	05-15	MT
Danaher Insider Sold Shares Worth $11,735,856, According to a Recent SEC Filing	05-13	MT
Raymond James Adjusts Price Target on Danaher to $285 From $270, Keeps Outperform Rating	04-29	MT
Danaher Insider Sold Shares Worth $5,618,569, According to a Recent SEC Filing	04-26	MT
Danaher Insider Sold Shares Worth $11,756,725, According to a Recent SEC Filing	04-25	MT
Danaher Insider Sold Shares Worth $1,000,040, According to a Recent SEC Filing	04-25	MT
HSBC Adjusts Danaher's Price Target to $290 From $280	04-24	MT
TD Cowen Adjusts Price Target on Danaher to $290 From $280	04-24	MT
Barclays Adjusts Price Target on Danaher to $270 From $260	04-24	MT
Citigroup Adjusts Price Target on Danaher to $290 From $280	04-24	MT
Baird Adjusts Danaher Price Target to $271 From $259	04-24	MT
Leerink Partners Adjusts Danaher Price Target to $275 From $265	04-24	MT
RBC Raises Price Target on Danaher to $297 From $284, Keeps Outperform Rating	04-24	MT
Goldman Sachs Raises Danaher Price Target to $220 from $215	04-23	MT
Evercore ISI Adjusts Price Target on Danaher to $266 From $260	04-23	MT
HSBC Upgrades Danaher to Buy From Hold, Adjusts Price Target to $280 From $250	04-17	MT
ANALYST RECOMMENDATIONS : Las Vegas Sands, Regeneron, Kinder Morgan, Rivian, Royal Caribbean...	04-17
Leerink Partners Adjusts Danaher's Price Target to $265 From $255	04-12	MT
RBC Lifts Price Target on Danaher to $284 From $282, Keeps Outperform Rating	04-08	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Danaher Corporation Nyse

Equities

DHR PRA

US2358513008

Analyst Reco.

Filters